The potential protective benefits associated with GLP-1 RAs reported in our study were primarily observed in new-onset HF, AKI or ESKD, VHD, cor pulmonale, and potential cardiac arrhythmia. This evidence concerns the gene GLP1R and cardiac rhythm disease.